Patheon signs expanded manufacturing agreement with Merck & Co., Inc.

Patheon designated as a 'preferred supplier' to Merck

14-Jun-2010 - Patheon announced that it has signed an expanded contract manufacturing agreement with Merck & Co., Inc. "We have developed a great partnership with Merck and are very pleased that they have chosen to expand it with this contract manufacturing agreement," said Wes Wheeler, Chief Executive ...

Patheon Inc. signs two 5-year manufacturing agreement renewals with Sanofi-Aventis

Agreements extend long standing manufacturing partnership between the companies

13-Jan-2010 - Patheon announced that it has signed two 5-year manufacturing agreements with Sanofi-Aventis. These agreements, for products manufactured in Patheon's Swindon and Bourgoin facilities, extend the company's longstanding partnership with Sanofi-Aventis to provide high quality outsourced ...

Lonza Announces Withdrawal of Bid for Patheon

20-Oct-2009 - Lonza Group AG announced that it has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of Patheon Inc at a price of US$3.55 per restricted voting share. While Lonza continues to believe that entry into the formulation contract ...

Patheon and Lonza Agree to Extend Exclusivity Period

19-Oct-2009 - Lonza Group AG and the Special Committee of Independent Directors of Patheon Inc. announced the extension of the exclusivity period granted to Lonza by Patheon, which had been scheduled to expire. The extension allows for continued discussions regarding possible strategic transactions between ...

Lonza Group AG Submits Non-binding Proposal to Acquire All Patheon Inc. Restricted Voting Shares

24-Aug-2009 - The Special Committee of Independent Directors of Patheon Inc. and Lonza Group AG announced that Lonza has submitted a non-binding proposal to acquire all of the outstanding Restricted Voting Shares of Patheon at a price of USD 3.55 per Restricted Voting Share. “Our interest in Patheon is ...

Patheon signs strategic alliance agreement with Kemwell

Expanding Capabilities to India

03-Apr-2009 - Patheon announced it has entered into a strategic alliance agreement with Kemwell Pvt. Limited, provider of formulations contract manufacturing and development services based in Bangalore, India. The alliance allows Patheon and Kemwell to refer and market each others' services to clients to ...

Patheon and Senopsys Announce Alliance

19-Nov-2008 - Patheon and Senopsys LLC have formed an alliance to develop dose formulations which enhance palatability (taste) for drugs that are in development. The alliance between Patheon and Senopsys is intended to deliver patient accepted pediatric formulations, line extension products and reformulated ...

Patheon Announces Expansion of Manati Puerto Rico Facility for High Potency Manufacturing

13-Jun-2008 - Patheon Inc. announced it will expand the Manati, Puerto Rico facility to add a dedicated high potency and controlled substance manufacturing area. Patheon will invest a total of $2.8 million in this new 3,386ft(2) area that will include three manufacturing suites, air lock containment areas, and ...

Patheon Announces Japanese Subsidiary Patheon, K.K.

06-Jun-2008 - Patheon Inc. announced the establishment of a Japanese subsidiary based in Tokyo, Japan. Patheon K.K. will operate from a newly established business office located in the Nihonbashi district of central Tokyo and will support Patheon's business requirements in the region. "This provides Patheon ...

Patheon completes York Mills facility sale

22-Apr-2008 - Patheon announced the completion of the sale of its York Mills facility located in Toronto, Canada for CDN$12.5 million (US$12.3 million) effective April 15, 2008. The agreement to sell the facility for a purchase price of CDN$12.5 million (US$12.3 million) was entered into on December 31, 2007 ...